TSS
CPIX icon

Two Sigma Securities’s Cumberland Pharmaceuticals CPIX Stock Holding History

Two Sigma Securities’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,354
Closed -$104K – 2163
2021
Q4 		$104K Buy
+22,354
New +$76.2K ﹤0.01% 1178

Other funds holding CPIX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's CPIX Position: Q1 2022 in Review

Two Sigma Securities sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2022, closing a stake of 22,354 shares — an estimated $104K sold.

Two Sigma Securities first reported a position in CPIX in Q4 2021 and held it in 1 quarter. The position peaked at $104K in Q4 2021. 26 funds tracked by Wall St. Rank hold CPIX as of Q1 2022.

  • Two Sigma Securities reported no remaining Cumberland Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Securities sold 22,354 Cumberland Pharmaceuticals shares in Q1 2022, an estimated $104K.
  • Two Sigma Securities first reported a position in Cumberland Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Two Sigma Securities's Cumberland Pharmaceuticals position peaked at $104K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.